Case Study : All

An European pharma company was amid conducting clinical trials for their fixed dose combination (FDC) drug to treat diabetes type II. Client wanted to establish a very clear understanding about the benefits associated with this new FDC. View More

A Korean medical device company headquartered in Seoul wanted to understand the perception of American end users about their insulin pump that was positioned to compete with other premium insulin pumps. View More

Our client, a tier I pharmaceutical company headquartered in United States was interested in understanding the perception of KOLs in the field of hypertension for their new FDC product launch. View More